目的 探究炔雌醇环丙孕酮联合胰岛素增敏剂治疗多囊卵巢综合征疗效。方法 选取广东省第一荣军医院妇科2018年8月—2020年8月收治的100例多囊卵巢综合征患者作为研究对象,采用随机数字表法将患者分为对照组(n=50)和观察组(n=50),2组患者均给予炔雌醇环丙孕酮治疗,观察组此外联合胰岛素增敏剂治疗,比较2组患者治疗前、治疗30 d后血清性激素、抗缪勒管激素(AMH)水平、代谢指标水平以及临床疗效(包括排卵、妊娠等)。结果 治疗前,2组患者血清性激素、AMH水平比较,差异不具有统计学意义(P>0.05),治疗后,2组患者AMH、血清性激素水平均有所下降,且观察组低于对照组(P<0.05)。治疗前,2组患者代谢指标比较,差异不具有统计学意义(P>0.05),治疗后2组患者代谢指标水平均有所下降,且观察组低于对照组(P<0.05)。观察组治疗有效率高于对照组(P<0.05)。结论 使用单一药物治疗具有局限性,将炔雌醇环丙孕酮与胰岛素增敏剂相联合治疗能够有效降低患者胰岛素代谢指标水平以及性激素水平,提高患者受孕几率,具有良好的治疗效果。

Objective To explore the efficacy of ethinylestradiol and cyproterone combined with insulin sensitizer in the treatment of polycystic ovary syndrome. Methods A total of 100 patients with polycystic ovary syndrome treated in the Department of Gynecology of the First Invalids Hospital of Guangdong Province from August 2018 to August 2020 were selected as the research object. The patients were divided into control group (n=50) and observation group (n=50). The patients in both groups were given ethinylestradiol cyproterone. In addition, the observation group was treated with insulin sensitizer. The levels of serum sex hormone, anti-Müllerian hormone (AMH), metabolic index level and clinical efficacy (including ovulation, pregnancy, etc.) before treatment and 30 days after treatment were compared. Results Before treatment, the levels of serum sex hormone and AMH had no significant difference between two groups (P>0.05). After treatment, the levels of AMH and serum sex hormone both decreased in two groups, and those in observation group were lower than those in control group (P<0.05). Before treatment, it had no significant difference in metabolic indexes (P>0.05). After treatment, the levels of metabolic indexes in the two groups decreased, and those in observation group were lower than those in control group (P<0.05). The effective rate of the observation group was higher than the control group (P<0.05). Conclusions Using single drug treatment has limitations. The combination of ethinylestradiol cyproterone and insulin sensitizer can reduce insulin metabolism and sex hormone levels, improve the probability of pregnancy, which have a good therapeutic effect.

目的 观察及探讨电子纤维喉镜抽吸法结合保守疗法治疗成年人分泌性中耳炎与单纯保守疗法治疗成年人分泌性中耳炎的疗效对比。 方法 86例成年人分泌性中耳炎患者按就诊先后顺序分成电子纤维喉镜抽吸法结合保守疗法治疗组及单纯保守疗法对照组两组,治疗6个月后, 统计分析临床治疗情况。 结果 电子纤维喉镜抽吸法结合保守疗法治疗组的临床疗效明显优于单纯保守疗法对照组 (P<0.05)。结论 电子纤维喉镜抽吸法结合保守疗法是一种高效、副作用小的治疗成年人分泌性中耳炎的方法,明显改善患者的症状、体征,提高疗效,缩短疗程,降低鼓膜穿刺及中耳手术概率。

Objective To observe and explore the difference on the treatment of secretory otitis media between the effect of electronic fiber laryngoscope suction combined with conservative therapy and the effect of the simple conservative therapy only. Methods The 86 adult patients with secretory otitis media were divided into two groups according to the order of treatment, One group used the electronic fiber laryngoscope suction combined with conservative therapy and the other used simple conservative therapy. After 6 months of treatment, the clinical treatment was statistically analyzed. Results The group used the electronic fiber laryngoscope suction combined with conservative therapy has a better effect(P<0.05). Conclusion The treatment of secretory otitis media electronic fiber laryngoscope suction combined with conservative therapy is a high efficiency and less side effect. What more, it improves the patient's symptoms, improves the curative effect and shortens the course of treatment and reduce the probability of tympanic membrane puncture and surgery.

目的 研究探讨复合式小梁切除术治疗原发性闭角型青光眼(primary angel closure glaucoma,PACG)的疗效。方法 选取2017年6月—2019年5月我院眼科收治的PACG患者86例(98眼),所有患者入院前均确诊,按照随机数字表法分为对照组和研究组各43例。对照组以传统小梁切除术、研究组以复合式小梁切除术治疗,对比滤过泡情况、中央前房深度(CACD)、眼压(IOP)及并发症发生率。结果 研究组术后1个月、6个月Ⅰ~Ⅱ型滤过泡形成率均高于对照组,(P＜0.05)。术前,两组CACD、IOP对比差异无统计学意义(P＞0.05);术后1 d、1个月,研究组CACD均高于对照组,研究组IOP均低于对照组,(P＜0.05);术后6个月,两组IOP比较无统计学意义(P＞0.05);两组并发症比较,对照组并发症发生率38.00%,研究组6.25%,研究组低于对照组(P＜0.05)。结论 以复合式小梁切除术治疗PACG,能够促进功能性滤过泡形成、前房及IOP恢复,并能够减少并发症,临床效果优于传统小梁切除术。

目的 本研究旨在探讨颈椎手法治疗对颞下颌关节紊乱症患者的疗效,为其临床应用及推广提供依据。方法 将符合入组条件的40例诊断为颞下颌关节紊乱症的患者随机分为实验组(20例)和对照组(20例)。对照组给予物理治疗,包括超声波及超短波治疗。实验组除与对照组一样的物理治疗外,还给予手法治疗,包括椎旁软组织放松按摩,颈椎复位及枕后肌群抑制技术。两组的治疗均持续2周,每周5次,总共10次。两组患者分别在治疗前和治疗后评估其咬肌的压痛阈值、最大张口度、咀嚼肌(咬肌和颞肌)在静息状态下表面肌电平均电位、咀嚼肌在最大用力状态下表面肌电峰值均值,并计算咀嚼肌不对称性指数、总体活动不对称性指数。结果 组内前后比较:对照组患者治疗后仅部分咀嚼肌的静息电位、最大张口度和咬肌压痛阈值的改变有统计学意义(P<0.05);实验组治疗后所有的指标的改变均有统计学意义(P<0.05)。组间比较:通过比较两组治疗前后的差值,结果显示所有指标改变都有统计学意义(P<0.05)。实验组的静息电位和咀嚼肌不对称性指数下降更多(P<0.05),而最大张口度和咬肌压痛阈值增加得更多(P<0.05)。结论 相比单纯运用理疗的方式,采用颈椎手法治疗联合物理治疗对颞下颌关节紊乱患者,其疗效更加明显。

目的 观察手指点穴结合利水消散包外敷对癌性腹水的疗效。方法 选择我科收治的癌性腹水患者60例为研究对象,随机分为对照组和治疗组各30例。对照组常规限水、限钠、利尿护理,治疗组在常规护理的基础上,实施手指点穴结合利水消散包外敷腹部,7天为1疗程,共干预3个疗程后进行疗效评价,观察两组患者治疗前后体质量、腹围变化、生活质量评分(KPS)。结果 治疗组总有效率为86.66%,对照组为56.67%,治疗组临床疗效优于对照组(P＜0.05),两组治疗后平均体质量、腹围均比本组治疗前降低,且治疗组治疗前后差值大于对照组(P＜0.05),治疗组治疗后KPS评分也高于对照组(P＜0.05)。结论 手指点穴结合利水消散包外敷对癌性腹水有减轻疗效,能改善患者生活质量,操作简单,成本低,易被患者接受,适宜在临床应用。

Objective To observe the efficacy of finger-pointing combined with the dispersal package of outer application of the water to cancerous ascites. Methods 60 patients with cancerous ascites were selected as study subjects, randomly divided into treatment group and control group, with 30 cases each. The control group of patients using conventional water limit, sodium limit, diuretic car,in treatment group, on the basis of conventional care, the implementation of finger-pointing combined with water dissipation package outside the abdoment was take.We took the navel as the center,7 days for 1 course of treatment.After a total of 3 courses of intervention, the efficacy evaluation was carried out, to observe the two groups of patients before and after treatment in weights, abdominal circumference changes, qualities of life score (KPS). Results The total efficiency treatment group was 86.66%, the control group was 56.67%, the clinical efficacy of the treatment group was better than that of the control group (P <0.05), the average weight and abdominal circumference were lower after treatment in both groups than before treatment, and the difference between treatment group before and after treatment was greater than that of the control group (P <0.05), and the KPS score after treatment group was also higher than that of the control group (P<0.05). Conclusion Finger point slot combination with the ex-envelope of water dissipation has reduced the effect of cancerous ascites, can improve the quality of life of patients, simple operation, low cost, easy to be accepted by patients, suitable for clinical application.

目的 探讨腹腔镜下卵巢癌减灭术联合化疗治疗卵巢癌的疗效。方法 选取2018年2月—2020年2月我院收治的68例卵巢癌患者,随机分为研究组和对照组各34例,对照组给予腹腔镜下卵巢癌减灭术,研究组给予腹腔镜下卵巢癌减灭术联合化疗。观察分析两组患者近期疗效、不良反应发生率、生存率以及相关手术情况等。结果 研究组近期疗效优于对照组(P＜0.05);研究组术后1年生存率高于对照组(P＜0.05),且并发症发生率低于对照组(P＜0.05);研究组理想减灭率优于对照组(P＜0.05),且腹水量及术中出血量少于对照组(P＜0.05),手术时间短于对照组(P＜0.05)。结论 减灭术联合化疗治疗卵巢癌可有效增强治疗疗效,降低多种化疗不良反应发生的可能性,并能使生存率得到进一步提升,可推广应用。

Objective To investigate the efficacy of laparoscopic ovarian cancer reduction combined with chemotherapy in the treatment of ovarian cancer. Methods A total of 68 ovarian cancer patients admitted to our hospital from February 2018 to February 2020 were randomly divided into study group and control group, 34 cases each. The control group was given laparoscopic ovarian cancer reduction surgery, while the study group was given laparoscopic ovarian cancer reduction surgery combined with chemotherapy. The short-term efficacy, incidence of adverse reactions, survival rate and related operation of the two groups were observed and analyzed. Results The short-term efficacy of the study group was better than that of the control group (P<0.05). The 1-year postoperative survival rate of the study group was higher than that of the control group (P<0.05), and the incidence of complications was lower than that of the control group (P<0.05). The ideal reduction rate of the study group was better than that of the control group (P<0.05), and the amount of abdominal water and intraoperative blood loss was less than that of the control group (P<0.05), and the operation time was shorter than that of the control group (P<0.05). Conclusion Laparoscopic ovarian cancer reduction combined with chemotherapy can effectively enhance the therapeutic effect, reduce the possibility of multiple adverse reactions of chemotherapy, and further improve the survival rate, which can be popularized and applied.

目的 探讨玻璃体切除术联合玻璃体腔注射曲安奈德治疗特发性黄斑前膜患者疗效观察。方法 选取我院2018年1月—2020年1月特发性黄斑前膜(idiopathic macular epiretinal membrane, IMEM)患者38例。随机分为治疗组(18例,18眼)与对照组(20例,20眼)。治疗组在术中予以玻璃体切除联合黄斑前膜剥除及内界膜剥除术,并注入曲安奈德(triamcinolone acetonide,TA),对照组术中单纯行玻璃体切除联合黄斑前膜剥除及内界膜剥除术。比较两组患者手术前及手术后1月、3月、6月的最佳矫正视力(BCVA)及黄斑中心凹厚度数值(CMT)及房水白细胞介素-6(IL-6)的变化情况。结果 术中所有患者成功剥除黄斑前膜,术后所有患者均未出现玻璃体积血、视网膜脉络膜脱离及眼压增高等并发症。两组患者中,所有患者手术后BCVA均较手术前有所提高,且治疗组优于对照组,差异有统计学意义(P＜0.05)。手术后治疗组CMT下降幅度优于对照组,差异有统计学意义(P＜0.05)。手术后治疗组房水中IL-6水平明显低于对照组,差异有统计学意义(P＜0.05)。结论 玻璃体切割及内界膜剥除术联合玻璃体腔内注射TA治疗IMEM,有助于提高患者术后视力,降低患者黄斑中心凹厚度,减轻患者黄斑水肿程度,减少房水中白细胞介素-6的表达。

目的 研究鼻内镜下应用低温等离子高选择性翼管神经分支切断治疗变应性鼻炎患者的临床疗效。方法 选取我院2019年1月—2020年12月收治的60例变应性鼻炎患者,随机数字表法分为对照组(30例)和观察组(30例)。对照组行保守治疗,观察组行鼻内镜下低温等离子高选择性翼管神经分支切断术治疗。比较两组治疗前后Lund—Kennedy内镜黏膜形态评分、视觉模拟量表(VAS)评分,分析两组治疗前后炎症细胞因子[血清肿瘤坏死因子-α(TNF-α)、白介素-4(IL-4)、白介素-6(IL-6)]及鼻黏膜功能指标[血管活性常态肠肽(VIP)、鼻腔阻力(NR)、鼻黏膜纤毛传输时间(MTT)、鼻黏膜纤毛输送率(MTR)]变化情况。结果 两组治疗后VAS评分、Lund—Kennedy评分较治疗前降低(P＜0.05);观察组治疗后VAS评分、Lund—Kennedy评分低于对照组(P＜0.05)。两组治疗后TNF-α、IL-4、IL-6水平较治疗前降低(P＜0.05);观察组治疗后TNF-α、IL-4、IL-6水平低于对照组(P＜0.05)。两组治疗后VIP、NR、MTT水平较治疗前降低(P＜0.05),MTR水平较治疗前升高(P＜0.05);观察组治疗后VIP、NR、MTT水平低于对照组(P＜0.05),MTR水平高于对照组(P＜0.05)。结论 鼻内镜下应用低温等离子高选择性翼管神经分支切断术治疗变应性鼻炎疗效显著,可改善鼻腔黏膜功能,减轻炎症反应,值得推广。

目的 分析基底节区脑出血患者接受神经内镜手术治疗的疗效。方法 将2019年6月—2020年8月接诊且行开颅血肿清除术的33例基底节区脑出血患者作为对照组,将同期接诊且行神经内镜手术的33例基底节区脑出血患者作为观察组,对组间美国国立卫生研究院卒中量表(NIHSS)、独立功能量表(FIM)、日常生活能力(ADL)评分、手术情况、血清水通道蛋白4(AQP4)水平、脑水肿体积、并发症情况展开分析。结果 (1)组间NIHSS、FIM、ADL评分在术前无明显差异,P>0.05;术后,观察组NIHSS评分更低,且FIM、ADL评分更高,P<0.05;(2)观察组骨窗大小(2.53±0.66)cm、切口长度(4.22±0.67)cm、术中失血量(47.58±11.25)mL、手术用时(1.58±0.42)h均少于对照组(10.88±1.13)cm、(11.84±2.31)cm、(149.83±33.76)mL、(2.99±0.63)h,且血肿清除率(88.84±9.62)%大于对照组(75.31±7.24)%,P<0.05;(3)观察组术后1周、术后2周、术后1个月时的AQP4水平、脑水肿体积均小于对照组,P<0.05;(4)观察组发生1例并发症(3.03%),对照组发生7例并发症(21.21%),P<0.05。结论 对基底节区脑出血患者进行神经内镜手术治疗,手术创伤小,可以降低AQP4水平,减少脑水肿体积及并发症,提高生活能力,值得推广。

Objective To analyze the curative effect of neuroendoscopic surgery in patients with basal ganglia intracerebral hemorrhage. Methods From June 2019 to August 2020, 33 patients with basal ganglia intracerebral hemorrhage who received craniotomy and hematoma clearance were selected as the control group, and 33 patients with basal ganglia intracerebral hemorrhage who received neuroendoscopic surgery at the same period were selected as the observation group. NIHSS,FIM and ADL scores,details of the surgery, levels of AQP4, brain edema volume and complications were analyzed. Results (1) There were no significant differences in NIHSS, FIM and ADL scores between the two groups before operation, P＞0.05; after operation, NIHSS score of the observation group was lower, and FIM and ADL scores were higher, P＜0.05. (2) Bone window size of the observation group was (2.53±0.66) cm, incision length was (4.22±0.67) cm, intraoperative blood loss was (47.58±11.25) mL, and operation time was (1.58±0.42) h, which were less than those of the control group [(10.88±1.13) cm and (11.84±2.31) cm, (149.83±33.76) mL, (2.99±0.63) h], and the hematoma clearance rate (88.84±9.62)% was higher than that of the control group (75.31±7.24)%, P＜0.05. (3) The AQP4 level and brain edema volume of the observation group 1 week, 2 weeks and 1 month after operation were lower than those of the control group, P＜0.05. (4) There was one complication (3.03%) in the observation group and seven complications (21.21%) in the control group,P<0.05. Conclusion Neuroendoscopic surgery for patients with basal ganglia cerebral hemorrhage can reduce the level of AQP4, the volume of brain edema and complications, and improve the ability of life, which is worthy of promotion.

目的 探讨经子宫后路子宫修补术联合血管阻断治疗前置胎盘的临床效果,旨在为临床治疗提供参考依据。方法 回顾性分析2018年2月—2020年2月本院收治的86例前置胎盘患者临床资料,依据治疗方式不同分为实验组(n=50)与对照组(n=36),两组患者均开展子宫修补术,对照组增加低位腹主动脉球囊阻断术,实验组增加血管阻断治疗。对比两组患者非产科因素并发症率、围术期相关指标及新生儿结局。结果 实验组非产科因素并发症率低于对照组,差异有统计学意义(P＜0.05);两组患者手术时间、住院时间、术中出血量、血浆输入量比较,差异无统计学意义(P＞0.05);两组新生儿Apgar评分、窒息率及体质量比较,差异无统计学意义(P＞0.05)。结论 前置胎盘患者在子宫后路子宫修补术基础上开展血管阻断进行干预,与低位腹主动脉球囊阻断术治疗效果差异性较小,但血管阻断治疗可避免X线对机体产生辐射,进而降低非产科因素并发症率,不良反应小,安全性较高,值得临床推广。